Register 2 & get 3rd FREE (Only $1395pp & group discounts available). Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Day One Summit – Wednesday, 5th October, 2022
Simon Curtis
Co-Founder & Chief Executive Officer
Curtis & Coulter
Targeted and Modified Delivery of Molecules to Improve Bioavailability: A Patient-Centric Journey
Dipen Desai, PhD
Vice President, Complex Product Development
Amneal Pharmaceuticals
10:00am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
OptiForm® Solution Suite – Catalent’s Early Development Toolkit for Resolving Small Molecule Oral Bioavailability Challenges in Preclinical Phase
• PBPK modelling to review permeability and other absorption challenges
• Beginning the transition from API to drug product using material sparing and risk mitigating approaches in animal PK evaluations
• Case examples showing the benefit of working with an experienced CDMO
• Faster to Phase 1 with dosage form flexibility
Stephen Tindal, PhD
Director, Science & Technology
Sponsored by:
10:40am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Overcoming Bioavailability Challenges of Peptide-Based Drug Product Development
Saji Vijayan, PhD
Vice President- R&D Strategy
Endo Pharmaceuticals
11:20am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Electrospinning as a Manufacturing Technique for Enabling Formulations
Sune Anderson, PhD
Principal Scientist, Spray Drying
12:00pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
V-Smart®: Novel Non-Invasive, Brain-Targeted Drug Delivery Platform
Susan Rosenbaum, JD
Founder & Chief Executive Officer
12:40pm
Virtual Lunch break
Grab a snack explore the Summit virtual platform, engage fellow attendees, and visit the Global Drug Bioavailability Enhancement Technology and Service companies solutions pages. Likewise, connect with other Summit attendees through our chat and networking portals.
Long Acting Injectables and Biopharmaceutics Implications
Manish Gupta, PhD
Senior Director, Sterile Drug Product Development, Pharmaceutical Development
2:00pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Improving Oral Bioavailability whilst Accelerating Product Development to the Clinic
Sudhakar Garad, PhD
Global Head of Chemical and Pharmaceutical Profiling
2:40pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Utilization of Physiologically Based Pharmacokinetic (PBPK) Modeling for Food Effect Prediction: Case Studies
Di Wu, PhD
Senior Scientist, Formulation Development
Merck & Co., Inc.
3:20pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Computer-Aided Prodrug Design
Dedong Wu, PhD
Senior Scientist, Solid State
AstraZeneca
3:55pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
4:00pm
Simon Curtis
Co-Founder & Chief Executive Officer
Curtis & Coulter
Day Two Virtual Summit – Thursday 4th November, 2021
Simon Curtis
Co-Founder & Chief Executive Officer
Curtis & Coulter
Innovations within Characterization of Amorphous Materials to Advance Product Development
Eric Munson, PhD
Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences
10:00am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
10:10am
Bioavailability Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance
Dabing Chen, PhD
Senior Principal Scientist
Boehringer Ingelheim
10:40am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
Challenges in Development of Highly Drug Loaded, Redispersible API Nanoparticle Containing Tablets
Christoph Nüboldt
Senior Researcher
INVITE GmbH
11:20am
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
11:30am
A Novel Lymphatic/Brain Targeting Macromolecular Prodrug System
Stephen Stern, PhD
Director of Research and Development, Head of the Pharmacology and Toxicology Section
Nanotechnology Characterization Laboratory
12:00pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
12:10pm
Expanding QC Dissolution Through Human Relative Bioavailability Study of a Slowly Eroding Amorphous Solid Dispersion Tablet
Melanie Marota, PhD
Associate Principal Scientist, Pharmaceutical Sciences
Merck & Co.
12:40pm
Virtual Lunch break
Grab a snack explore the Summit virtual platform, engage fellow attendees, and visit the Global Drug Bioavailability Enhancement Technology and Service companies solutions pages. Likewise, connect with other Summit attendees through our chat and networking portals.
1:30pm
Oral Bioavailability Enhancement via Supersaturation and Precipitation
Ajit Narang, PhD
Principal Scientist, Small Molecule Pharmaceutics and Biopharmaceutics
1:55pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
2:00pm
Melt Extrusion Deposition (MED®) 3D Printing for the Challenging Pharmaceutical Products
Xin Liu, PhD
Associate Director of Pharmaceutical Product Development
Triasek
2:25pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
2:30pm
Bespoke Dosing for Pediatric Patients
Rick Panicucci, PhD
Senior Vice President, CMC
QED Therapeutics
2:55pm
SUMMIT NETWORKING SLOT
Explore the Summit virtual platform, schedule meetings, connect with fellow Summit attendees, and visit the Global Drug Bioavailability Enhancement Summit partner CDMOs and technology companies.
3:00pm
Mesoporous Silica Technology: A Solubility Enhancement Oral Delivery System for Poorly Soluble Drugs
Shih-Wen Wang, PhD
Senior Associate Scientist
3:20pm
Simon Curtis
Co-Founder & Chief Executive Officer
Curtis & Coulter
Attend
Meet 120+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!
Sponsorship
Take advantage of the unique opportunity to engage your direct target audience face-to-face, and help them overcome their product challenges in 2 full interactive days!